Related references
Note: Only part of the references are listed.Oral Administration of Flavonifractor plautii Strongly Suppresses Th2 Immune Responses in Mice
Tasuku Ogita et al.
FRONTIERS IN IMMUNOLOGY (2020)
Alginate/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model
Cao Jin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Microbial therapeutics: New opportunities for drug delivery
Miguel Jimenez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Evan Bolyen et al.
NATURE BIOTECHNOLOGY (2019)
Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice
Jianyong Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Gut microbiota and IBD: causation or correlation?
Josephine Ni et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases
Suguru Shigemori et al.
FRONTIERS IN IMMUNOLOGY (2017)
Class A CpG Oligonucleotide Priming Rescues Mice from Septic Shock via Activation of Platelet-Activating Factor Acetylhydrolase
Yoshinari Yamamoto et al.
FRONTIERS IN IMMUNOLOGY (2017)
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
Paul W. O'Toole et al.
NATURE MICROBIOLOGY (2017)
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan et al.
NATURE METHODS (2016)
Infecções graves em pacientes com artrite reumatoide em uso de anakinra, rituximab ou abatacept: revisão sistemática de estudos observacionais
Vanderlea Poeys Cabral et al.
Revista Brasileira De Reumatologia (2016)
Inhibitory/Suppressive Oligodeoxynucleotide Nanocapsules as Simple Oral Delivery Devices for Preventing Atopic Dermatitis in Mice
Yeqin Wang et al.
MOLECULAR THERAPY (2015)
IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
Reiner K. W. Mailer et al.
SCIENTIFIC REPORTS (2015)
Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice
Suguru Shigemori et al.
MICROBIAL CELL FACTORIES (2015)
Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci
Luis G. Bermudez-Humaran et al.
MICROBIAL CELL FACTORIES (2015)
Secretion of biologically active human interleukin 22 (IL-22) by Lactococcus lactis
Maria J. Loera-Arias et al.
BIOTECHNOLOGY LETTERS (2014)
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Miranda L. Hanson et al.
GASTROENTEROLOGY (2014)
Excess IL-1 Signaling Enhances the Development of Th17 Cells by Downregulating TGF-β-Induced Foxp3 Expression
Satoshi Ikeda et al.
JOURNAL OF IMMUNOLOGY (2014)
A Polysaccharide Virulence Factor from Aspergillus fumigatus Elicits Anti-inflammatory Effects through Induction of Interleukin-1 Receptor Antagonist
Mark S. Gresnigt et al.
PLOS PATHOGENS (2014)
Generation of Dipeptidyl Peptidase-IV-Inhibiting Peptides from beta-Lactoglobulin Secreted by Lactococcus lactis
Suguru Shigemori et al.
BIOMED RESEARCH INTERNATIONAL (2014)
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells
Margherita Coccia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Postinfectious Irritable Bowel Syndrome: A Genetic Link Identified?
Severine Vermeire et al.
GASTROENTEROLOGY (2010)
AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis
Silvia Caluwaerts et al.
ORAL ONCOLOGY (2010)
Enhanced Secretion of Biologically Active Murine Interleukin-12 by Lactococcus lactis
Antonio Fernandez et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
Nisin-controlled extracellular production of interleukin-2 in Lactococcus lactis strains, without the requirement for a signal peptide sequence
Antonio Fernandez et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin
Inge L. Huibregtse et al.
GASTROENTEROLOGY (2007)
Secretion of biologically active porcine interleukin-2 by Lactococcus lactis
Sija Avall-Jaaskelainen et al.
VETERINARY MICROBIOLOGY (2006)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis
I Mierau et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease
O Ludwiczek et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production
LG Bermúdez-Humarán et al.
INFECTION AND IMMUNITY (2003)
Survival of lactococci during passage through mouse digestive tract
H Kimoto et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2003)
IL-1β-converting enzyme (caspase-1) in intestinal inflammation
B Siegmund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
